Relationship Between %HRmax, %HR Reserve, %VO2max, and %VO2 Reserve in Elite Cyclists
Overview
Affiliations
Purpose: To evaluate the relations between %HRmax, %HRR, %VO2max, and %VO2R in elite cyclists and to check whether the intensity scale recommended by ACSM in its 1998 position stand is also applicable to this specific population.
Methods: Twenty-six male elite road cyclists (25.1 +/- 0.7 yr, 71.0 +/- 1.2 kg, 70.9 +/- 1.2 mL x kg(-1) x min(-1), 433.9 +/- 9.8 W) performed an incremental maximal exercise test (50 W x 3 min(-1)). Individual linear regressions based on HR and VO2 values measured at rest, end of each stage, and maximum, were used to calculate slopes and intercepts, and to predict %HRmax, %HRR, %VO2max, or %VO2R for a given exercise intensity.
Results: Below 85% VO2max or VO2R, predicted %HRmax values were significantly higher (P < 0.001) than the ACSM intensity scale (58, 65, 73, and 87% vs 55, 62, 70, and 85% HRmax at 40, 50, 60, and 80% VO2max, and 48, 61, 74% vs 35, 55, and 70% HRmax at 20, 40, and 60% VO2R). The %HRR versus %VO2max regression mean slope (1.069 +/- 0.01) and intercept (-5.747 +/- 0.80) were significantly different (P < 0.0001) from 1 and 0, respectively. Conversely, the %HRR versus %VO2R regression was indistinguishable from the line of identity (mean slope = 1.003 +/- 0.01; mean intercept = 0.756 +/- 0.7). Predicted %VO2R values were equivalent to %HRR in the 35-95%HRR range. %VO2max was equivalent to %HRR at and above 75%HRR, and it was significantly higher at (P < 0.05) and below 65%HRR (P < 0.001).
Conclusion: The intensity scale recommended by ACSM underestimates exercise intensity in elite cyclists. Prediction of %HRR by %VO2R is better than by %VO2max. Thus, elite cyclists should use %HRR in relation to %VO2R rather than in relation to %VO2max.
Schumann M, Feuerbacher J, Heinrich L, Olvera-Rojas M, Sclafani A, Brond J Sports Med. 2025; .
PMID: 39893599 DOI: 10.1007/s40279-024-02159-1.
Hebisz R, Hebisz P PLoS One. 2024; 19(11):e0311833.
PMID: 39536034 PMC: 11559993. DOI: 10.1371/journal.pone.0311833.
Tomaszewski M, Lukanova-Jakubowska A, Majorczyk E, Dzierzanowski L PLoS One. 2024; 19(8):e0309427.
PMID: 39208146 PMC: 11361594. DOI: 10.1371/journal.pone.0309427.
Ferri Marini C, Micheli L, Grossi T, Federici A, Piccoli G, Zoffoli L PeerJ. 2024; 12:e17158.
PMID: 38711624 PMC: 11073009. DOI: 10.7717/peerj.17158.
Chiang C, Wang Z, Hsu Y, Miaw S, Lin W PLoS One. 2023; 18(7):e0288380.
PMID: 37437011 PMC: 10337956. DOI: 10.1371/journal.pone.0288380.